SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Applied Biologics Announces Publication of CAMPX Interim Trial Results

Applied Biologics announced publication of interim CAMPX trial results in a peer-reviewed journal.

SquawkNews Desk 1 updates Updated Oct 28, 2026, 01:39 PM UTC

Story updates

01:39:25 PM UTC
SquawkNews
Applied Biologics Announces Publication of Peer-Reviewed CAMPX Interim Trial Results in the Journal

Related stories

Alnylam Reports Quarterly Results Through September 30 Alnylam Pharmaceuticals reported results for the quarter ended September 30. The alert provides no financial figures. M impact | EQUITY | Oct 29, 2026, 07:15 PM UTC Riverview Bancorp Reports $2.0 Million Second-Quarter Profit Riverview Bancorp reported net income of $2.0 million, or $0.10 per diluted share, for the fiscal second quarter ended September 30, 2026. Net interest income was $11.8 million and M impact | EQUITY | Oct 29, 2026, 07:13 PM UTC Ligand Pharmaceuticals Reports Quarterly Results Through September 30 M impact | EQUITY | Oct 29, 2026, 07:13 PM UTC Allegro Microsystems Reports Quarterly Results Through September 30 M impact | EQUITY | Oct 29, 2026, 07:12 PM UTC Group 1 Automotive Reports Third-Quarter Revenue of $5.4B Third-quarter revenue fell 6.7% year over year to $5.4 billion. Net income rose to $102.9 million from $13 million; diluted EPS was $8.59. M impact | EQUITY | Oct 29, 2026, 07:11 PM UTC Visa Publishes Q4 and Full-Year 2026 Earnings Call Transcript M impact | EQUITY | Oct 29, 2026, 07:11 PM UTC